A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells

Journal of Biomolecular Screening

Volumn 17, Issue 9, 2012, Pages 1231-1242

  Mathews, Lesley A ^a   Keller, Jonathan M ^a   Goodwin, Bonnie L ^a   Guha, Rajarshi ^a   Shinn, Paul ^a   Mull, Rebecca ^a   Thomas, Craig J ^a   De Kluyver, Rachel L ^b   Sayers, Thomas J ^c   Ferrer, Marc ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c SAIC FREDERICK INC   (United States)

Author keywords

cancer stem cells; pancreatic cancer; prostate cancer; qHTS

Indexed keywords

ANTINEOPLASTIC AGENT; BORTEZOMIB; CMP1; CMP1 S; SALINOMYCIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STEM CELL; CELL ASSAY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG POTENCY; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HIGH-THROUGHPUT SCREENING ASSAYS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; NEOPLASMS; NEOPLASTIC STEM CELLS; SMALL MOLECULE LIBRARIES;

EID: 84866423721     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057112458152     Document Type: Article

References (35)

1. Jemal A., Siegel R. Cancer Facts and Figures. American Cancer Society: Atlanta, GA ; 2011:
2. Moss R. A., Lee C. Current and Emerging Therapies for the Treatment of Pancreatic Cancer. Oncol. Targets Ther. 2010 ; 3: 111-127
3. Shah A. N., Summy J. M., Zhang J., Park S. I., Parikh N. U., Gallick G. E. Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells. Ann. Surg. Oncol. 2007 ; 14 (12). 3629-3637
4. Ischenko I., Seeliger H., Jauch K. W., Bruns C. J. Metastatic Activity and Chemotherapy Resistance in Human Pancreatic Cancer-Influence of Cancer Stem Cells. Surgery. 2009 ; 146 (3). 430-434
5. Merl M. Y., Li J., Saif M. W.. The First-Line Treatment for Advanced Pancreatic Cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium." ; 2010 Orlando, FL, USA ; 2010. 148.
6. Crea F., Duhagon Serrat M. A., Hurt E. M., Thomas S. B., Danesi R., Farrar W. L. BMI1 Silencing Enhances Docetaxel Activity and Impairs Antioxidant Response in Prostate Cancer. Int. J. Cancer. 2010 ; 128 (8). 1946-1954
7. O'Brien C. A., Kreso A., Jamieson C. H. Cancer Stem Cells and Self-renewal. Clin. Cancer Res. 2010 ; 16 (12). 3113-3120
8. Sengupta A., Cancelas J. A. Cancer Stem Cells: A Stride towards Cancer Cure?. J. Cell Physiol. 2010 ; 225 (1). 7-14
9. Reiman J. M., Knutson K. L., Radisky D. C. Immune Promotion of Epithelial-Mesenchymal Transition and Generation of Breast Cancer Stem Cells. Cancer Res. 2010 ; 70 (8). 3005-3008
10. Raimondi C., Gianni W., Cortesi E., Gazzaniga P. Cancer Stem Cells and Epithelial-Mesenchymal Transition: Revisiting Minimal Residual Disease. Curr. Cancer Drug Targets. 2010 ; 10 (5). 496-508
11. Bhattacharyya S., Khanduja K. L. New Hope in the Horizon: Cancer Stem Cells. Acta Biochim. Biophys. Sin. (Shanghai). 2010 ; 42 (4). 237-242
12. Li C., Heidt D. G., Dalerba P., Burant C. F., Zhang L., Adsay V., Wicha M., Clarke M. F., Simeone D. M. Identification of Pancreatic Cancer Stem Cells. Cancer Res. 2007 ; 67 (3). 1030-1037
13. Dontu G., Abdallah W. M., Foley J. M., Jackson K. W., Clarke M. F., Kawamura M. J., Wicha M. S. In Vitro Propagation and Transcriptional Profiling of Human Mammary Stem/Progenitor Cells. Genes Dev. 2003 ; 17 (10). 1253-1270
14. Hurt E. M., Kawasaki B. T., Klarmann G. J., Thomas S. B., Farrar W. L. CD44+ CD24(-) Prostate Cells Are Early Cancer Progenitor/Stem Cells That Provide a Model for Patients with Poor Prognosis. Br. J. Cancer. 2008 ; 98 (4). 756-765
15. Gaviraghi M., Tunici P., Valensin S., Rossi M., Giordano C., Magnoni L., Dandrea M., Montagna L., Ritelli R., Scarpa A., et al. Pancreatic Cancer Spheres Are More Than Just Aggregates of Stem Marker Positive Cells. Biosci. Rep. 2010 ; 31 (1). 45-55
16. Gou S., Liu T., Wang C., Yin T., Li K., Yang M., Zhou J. Establishment of Clonal Colony-Forming Assay for Propagation of Pancreatic Cancer Cells with Stem Cell Properties. Pancreas. 2007 ; 34 (4). 429-435
17. Klarmann G. J., Hurt E. M., Mathews L. A., Zhang X., Duhagon M. A., Mistree T., Thomas S. B., Farrar W. L. Invasive Prostate Cancer Cells Are Tumor Initiating Cells That Have a Stem Cell-Like Genomic Signature. Clin. Exp. Metastasis. 2009 ; 26 (5). 433-436
18. Mathews L. A., Cabarcas S. M., Hurt E. M., Zhang X., Jaffee E. M., Farrar W. L. Increased Expression of DNA Repair Genes in Invasive Human Pancreatic Cancer Cells. Pancreas. 2011 ; 40 (5). 730-739
19. Duhagon M. A., Hurt E. M., Sotelo-Silveira J. R., Zhang X., Farrar W. L. Genomic Profiling of Tumor Initiating Prostatospheres. BMC Genomics. 2010 ; 11 (324). 1-16
20. Inglese J., Auld D. S., Jadhav A., Johnson R. L., Simeonov A., Yasgar A., Zheng W., Austin C. P. Quantitative High-Throughput Screening: A Titration-Based Approach That Efficiently Identifies Biological Activities in Large Chemical Libraries. Proc. Natl. Acad. Sci. U. S. A. 2006 ; 103 (31). 11473-11478
21. Wang Y., Jadhav A., Southal N., Huang R., Nguyen D. T. A Grid Algorithm for High Throughput Fitting of Dose-Response Curve Data. Curr. Chem. Genomics. 2010 ; 4: 57-66
22. Cabarcas S. M., Mathews L. A., Farrar W. L. The Cancer Stem Cell Niche-There Goes the Neighborhood?. Int. J. Cancer. 2012 ; 129 (10). 2315-2327
23. Gupta P. B., Onder T. T., Jiang G., Tao K., Kuperwasser C., Weinberg R. A., Lander E. S. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening. Cell. 2009 ; 138 (4). 645-659
24. Crea F., Mathews L. A., Farrar W. L., Hurt E. M. Targeting Prostate Cancer Stem Cells. Anticancer Agents Med. Chem. 2009 ; 9 (10). 1105-1113
25. Singh A., Settleman J. EMT, Cancer Stem Cells and Drug Resistance: An Emerging Axis of Evil in the War on Cancer. Oncogene. 2010 ; 29 (34). 4741-4751
26. Jeter C. R., Badeaux M., Choy G., Chandra D., Patrawala L., Liu C., Calhoun-Davis T., Zaehres H., Daley G. Q., Tang D. G. Functional Evidence That the Self-renewal Gene NANOG Regulates Human Tumor Development. Stem Cells. 2009 ; 27 (5). 993-1005
27. Jeter C. R., Liu B., Liu X., Chen X., Liu C., Calhoun-Davis T., Repass J., Zaehres H., Shen J. J., Tang D. G. NANOG Promotes Cancer Stem Cell Characteristics and Prostate Cancer Resistance to Androgen Deprivation. Oncogene. 2012 ; 30 (36). 3833-3845
28. Lu Y. H., Zhu H., Wang Z. W., Fan X. J., Zhu S. J., Li X. H., Wang Y., Lu J. J., Zhu M. Y. Altered Expressions of Embryonic Stem-Related Genes in Pancreatic Cancer Stem Cell [in Chinese]. Zhonghua Yi Xue Za Zhi. 2011 ; 91 (44). 3107-3110
29. Wen J., Park J. Y., Park K. H., Chung H. W., Bang S., Park S. W., Song S. Y. Oct4 and Nanog Expression Is Associated with Early Stages of Pancreatic Carcinogenesis. Pancreas. 2010 ; 39 (5). 622-626
30. Tang S. N., Fu J., Nall D., Rodova M., Shankar S., Srivastava R. K. Inhibition of Sonic Hedgehog Pathway and Pluripotency Maintaining Factors Regulate Human Pancreatic Cancer Stem Cell Characteristics. Int. J. Cancer. 2012 ; 131 (1). 30-40
31. Kim K. Y., Yu S. N., Lee S. Y., Chun S. S., Choi Y. L., Park Y. M., Song C. S., Chatterjee B., Ahn S. C. Salinomycin-Induced Apoptosis of Human Prostate Cancer Cells Due to Accumulated Reactive Oxygen Species and Mitochondrial Membrane Depolarization. Biochem. Biophys. Res. Commun. 2011 ; 413 (1). 80-86
32. Zhang G. N., Liang Y., Zhou L. J., Chen S. P., Chen G., Zhang T. P., Kang T., Zhao Y. P. Combination of Salinomycin and Gemcitabine Eliminates Pancreatic Cancer Cells. Cancer Lett. 2011 ; 313 (2). 137-144
33. Marten A., Zeiss N., Serba S., Mehrle S., von Lilienfeld-Toal M., Schmidt J. Bortezomib Is Ineffective in an Orthotopic Mouse Model of Pancreatic Adenocarcinoma. Mol. Cancer Ther. 2008 ; 7 (11). 3624-3631
34. Lelekakis M., Moseley J. M., Martin T. J., Hards D., Williams E., Ho P., Lowen D., Javni J., Miller F. R., Slavin J., et al. A Novel Orthotopic Model of Breast Cancer Metastasis to Bone. Clin. Exp. Metastasis. 1999 ; 17 (2). 163-170
35. Bolin C. M., Sutherland C., Tawara K., Moselhy J., Jorcyk C. L. Novel Mouse Mammary Cell Lines for In Vivo Bioluminescence Imaging (BLI) of Bone Metastasis. Biol. Proced. Online. 2012 ; 14 (1). 1-6